Various alphabetized medical records

Life Sciences Securities Litigation

CRA has a broad range of experience in complex shareholder lawsuits and appraisal disputes involving life sciences and healthcare companies. CRA assists clients across all phases of the securities litigation process, including responding to pre-litigation SEC investigations, class certification, discovery, materiality, loss causation, damages, and settlement negotiations. CRA supports clients in disputes arising from mergers and acquisitions by providing industry expertise in evaluating claims regarding drug development and commercialization and other issues. Our experts provide valuation opinions related appraisal lawsuits brought by dissenter or minority shareholders, and estimated damages related to shareholder disputes for breach of contingent valuation rights agreements.


  • 01
    Cigna-Anthem Merger Litigation
    CRA was retained by counsel for Cigna Corporation in a litigation in Delaware Chancery Court arising from its unsuccessful merger with Anthem, Inc. Both...
    View engagement
  • 02
    CRA evaluates commercial efforts to develop a MS drug with respect to contractual obligations following merger
    CRA assessed commercial efforts to develop and commercialize a MS drug with respect to obligations stemming from the acquisition of Genzyme Corporation by...
    View engagement
  • 03
    CRA expert testifies in Chapter 11 case on behalf of Debtor, LTL Management LLC
    CRA was retained on behalf of LTL Management LLC, the Debtor in a bankruptcy case to opine on the impact that talc tort litigation had on the Johnson & Johnson...
    View engagement

Contact a Life Sciences Securities Litigation expert.

See all Life Sciences Securities Litigation experts.

Subscribe to receive our latest Insights.